I am once again making MannKind Corp. (MNKD) my "Top Pick" for more aggressive investors in 2025, advises Nate Pile, editor of Nate’s Notes.

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions, and role in therapy of vildagliptin for the treatment of type 2 diabetes mellitus were reviewed.

People with diabetes who take insulin should have a prescription for either injectable glucagon or inhaled glucagon. In the event of a severe low-blood-sugar emergency, glucagon must be administered.

It also needs to make a success of inhaled insulin Afrezza, which the company licensed from MannKind last year to bolster its diabetes franchise, although some analysts have suggested it might be ...

By the time Enid Katz was two years old, she had already suffered through several bouts of bronchitis and was always hungry, ...

Another notable innovation in drug delivery in 2015 was MannKind and Sanofi's inhalable insulin Afrezza, launched in February. However the product looks set to be a resounding commercial failure ...

Background The study of endogenous insulin secretion may provide relevant insight into the comparison of the natural history of adult onset latent autoimmune diabetes (LADA) with types 1 and 2 ...

clinepi.mcgill.ca Background: Inhaled corticosteroids are effective at preventing asthma morbidity and mortality. Most studies, however, have focused on short term effects, raising uncertainty about ...

Drug major Cipla reported a 49% year-on-year jump in its December quarter consolidated net profit, reaching Rs 1,571 crore, compared to Rs 1,056 crore in the same period last year. The profit after ...